Who is sponsoring NCT01789268?

NCT01789268 is sponsored by University of Rochester.

What drugs are being tested in NCT01789268?

Interventions in NCT01789268: Respiratory Inductive Plethysmography.

What condition does NCT01789268 study?

NCT01789268 studies Respiratory Tract Infection.

Is NCT01789268 still recruiting?

NCT01789268 is currently completed. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT01789268

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Respiratory Pathogens in Infants

Completed Last updated 2 March 2022

What this trial tests

trial testing Respiratory Inductive Plethysmography in Respiratory Tract Infection in 267 participants. Completed in 31 December 2019.

Timeline

27 March 2013

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	University of Rochester
Status	Completed
Study type	OBSERVATIONAL
Enrollment	267
Start date	27 March 2013
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

Respiratory Inductive Plethysmography

Conditions studied

Respiratory Tract Infection — all drugs for Respiratory Tract Infection →

Sponsor

University of Rochester

Who can join

Adults 0 Days to 3, any sex, with Respiratory Tract Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study will investigate the relationships between sequential respiratory viral infections, patterns of intestinal and respiratory bacterial colonization, and adaptive cellular immune phenotypes which are associated with increased susceptibility to respiratory infections and long term respiratory morbidity in preterm and full term infants. This is a prospective, cohort study, enrolling at a single center via two sites (URMC and URMC-affiliated Highland Hospital and Rochester General Hospital). Enrollment will be accomplished in approximately 15 - 36 months. The study will enroll 280 subjects, 150 pre-term and 130 full-term.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Role of the microbiome in human development.
Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. · · 2019 · cited 517× · PMID 30670574 · DOI 10.1136/gutjnl-2018-317503
Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.
Pryhuber GS. · · 2015 · cited 26× · PMID 26593074 · DOI 10.1016/j.clp.2015.08.002
Aberrant newborn T cell and microbiota developmental trajectories predict respiratory compromise during infancy.
McDavid A, Laniewski N, Grier A, Gill AL, et al · · 2022 · cited 17× · PMID 35310935 · DOI 10.1016/j.isci.2022.104007
Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants.
Caserta MT, Yang H, Bandyopadhyay S, Qiu X, et al · · 2019 · cited 4× · PMID 31377041 · DOI 10.1016/j.jpeds.2019.06.061

Verify or expand the search:

Other trials of Respiratory Inductive Plethysmography

Trials testing the same drug.

NCT05196646 — Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP · active not recruiting

Other University of Rochester trials

Trials by the same sponsor.

NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1 · Phase 1 · not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi · Phase 2 · not yet recruiting
NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses · Phase 2 · not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01789268 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01789268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing